Immunization with analogue peptide in combination with CpG and Montanide expands tumor antigen-specific CD8+ T cells in melanoma patients

Analogue peptides represent a promising tool to further optimize peptide-based vaccines in promoting the expansion of tumor antigen-specific CTLs. Here, we report the results of a pilot trial designed to study the immunogenicity of the analogue peptide NY-ESO-1 157-165V in combination with CpG 7909/...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fourcade, Julien, Kudela, Pavol, Filho, Pedro A. Andrade, Janjic, Bratislav, Land, Stephanie R., Sander, Cindy, Krieg, Arthur, Donnenberg, Albert, Shen, Hongmei, Kirkwood, John M., Zarour, Hassane M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3901357/
https://ncbi.nlm.nih.gov/pubmed/18779741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e318183af0b
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky